<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ASLN
Aslan Pharmaceuticals
$
()


  • Aslan Pharmaceuticals to host KOL panel discussion on Dupilumab

    4/30/2024 - 07:20am
  • Biotech Alert: Searches spiking for these stocks today

    4/24/2024 - 10:53am
  • Aslan announces interim results from Phase 2 study of eblasakimab

    4/22/2024 - 08:54am
  • Aslan Pharmaceuticals receives Nasdaq notice

    4/19/2024 - 17:13pm
  • Aslan Pharmaceuticals reports Q4 EPS (3c) vs (4c) last year

    4/12/2024 - 08:02am
  • Aslan Pharmaceuticals files to sell 125M ordinary shares for holders

    3/25/2024 - 16:48pm
  • Aslan Pharmaceuticals price target lowered by $8 at H.C. Wainwright, here's why

    3/18/2024 - 06:13am
  • Biotech Alert: Searches spiking for these stocks today

    3/15/2024 - 11:32am
  • Biotech Alert: Searches spiking for these stocks today

    3/14/2024 - 11:01am
  • Biotech Alert: Searches spiking for these stocks today

    3/13/2024 - 11:07am
  • Aslan Pharmaceuticals price target lowered by $5 at Piper Sandler, here's why

    3/13/2024 - 06:50am
  • Aslan Pharmaceuticals announces $5M registered direct offering

    3/12/2024 - 14:37pm
  • Piper 'confident' partner or buyer will see benefit of Aslan's eblasakimab

    3/11/2024 - 14:45pm
  • Aslan Pharmaceuticals provides TREK-DX study update

    3/11/2024 - 07:14am
  • Aslan Pharmaceuticals announces new data on eblasakimab, appointments

    3/6/2024 - 07:11am
dynamic_feed Breaking News